有晶体眼人工晶体植入术治疗超高度近视的临床观察

Clinical research of implantation of phakic anterior chamber intraocular lens for high myopia

关键词:  高度近视  晶体植入  前房

Key words:  high myopia  lens implantation  anterior chamber

摘要:

［目的］ 探讨有晶体眼前房型人工晶体植入术治疗高度近视的临床效果。［方法］ 对近视度数在-8～-23D的110眼行有晶体眼前房型人工晶体植入术。手术前后检查：裸眼视力、矫正视力、眼压、角膜内皮细胞计数、房角镜、人工晶体及透明晶体情况。并对上述检查进行对比分析。术后随访12月。［结果］ 110眼均成功植入人前房人工晶体。裸眼视力术前0.01～0.1，术后82.73%≥0.3，33.64%≥0.6。术前眼压（13.54±0.64）mmHg；术后眼压（14.23±0.79）mmHg。角膜内皮细胞计数术前：（3108±297）个/mm2，术后（28774±301）个/ mm2，差异均无显著性意义。［结论］ 有晶体眼前房型人工晶体植入术可有效治疗超高度近视。手术具有安全性、有效性、可预测性及可逆性。

Abstract:

［Objective］ To evaluate the effect of anterior chamber intraocular lens implantation for high myopia. ［Methods］ One hundred ten eyes in 57 patients with 8.00 to 23.00 diopters of myopia were implanted with the intraocular lenses. These eyes then were checked with uncorrected visual acuity, corrected visual acuity, intraocular pressure (IOP) and corneal endothelial cells for 12 months post surgery.［Results］ All surgeries of the 110 eyes were successful. The uncorrected visual acuity was 0.01 to 0.1 pre-operatively. The corrected visual acuity was improved to 0.3 in 82.3%, and 0.6 in 33.64% of those patients post-operatively. Pre- and post-operative IOP were (13.54±0.64) mmHg and (14.23±0.79) mmHg respectively. Endothelial cells were (3108±197)/mm2 and (2877±201)/mm2, with no significant difference. ［Conclusions］ The implantation of phakic anterior chamber IOL for high myopia is effective, safe and predictable.